Methods
20/YH/0005, Phosphaturia
WEST, PHOSPHATURIA
The “Iron and Phosphaturia – ExplorIRON-CKD” (EudraCT number: 2019-004370-26) took place according to the Declaration of Helsinki and the Good Clinical Practice guidelines. Clinical trial authorization was provided by the Health Research Authority and the Medicines and Healthcare Products Regulatory Agency of the United Kingdom. The trial received the favorable opinion of the Research Ethics Committee Leeds West (20/YH/0005). All participants were enrolled only after full informed consent was taken.The baseline results and methodology of the present study have been previously published